MENU
ARDX
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Ardelyx (ARDX) Ownership - Who owns Ardelyx?
Ardelyx Inc is a biopharmaceutical company developing and commercialize, first-in-class medicines that meet unmet medical needs... Show more
Industry: #Biotechnology
Profile
Industry
Biotechnology
Address
400 Fifth Avenue
Phone
+1 510 745-1700
Employees
267
Web
https://www.ardelyx.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
949.84M
P/E Ratio
N/A
Total Cash
213.95M
Projected Growth
N/A
Total Debt
155.11M
Revenue
361.71M
Risk (Beta)
0.45
Dividend Yield
N/A
Total Cash/Share
0.89
Total Debt/Equity
N/A
Revenue/Share
1.53 USD as % of share price
Fundamentals
ARDX
Capitalization
950M
P/E Ratio
N/A
Risk (Beta)
0.45
Dividend Yield
N/A
Total Cash
214M
Total Cash/Share
0.89
Total Debt
155M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
1.53%
Revenue
362M
ROE
N/A
Book Value
146M
P/B Ratio
6.52
Cash Flow
N/A
Earnings
-0.23
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
24K
Current Ratio
4.12
Current Revenue Per Employee
187630.38
Dividends Per Share - Security
N/A
EBITDA
-28.23M
Float
N/A
Float - Current
N/A
Gross Income Margin
83.40
Revenue To Assets
-14.29
Shares Held By Institutions
1.37B
Shares Outstanding - Current
239M
Total Liabilities
265M
Total Volume MTD
N/A
Value
-1
Gain YTD
-21.696
View a ticker or compare two or three
VS
VS
Show more...
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
a developer of therapeutic drugs that work in the gastrointestinal tract to treat cardio-renal, GI and metabolic diseases
Industry Biotechnology
Profile
Fundamentals
Details
Industry
Biotechnology
Address
400 Fifth Avenue
Phone
+1 510 745-1700
Employees
267
Web
https://www.ardelyx.com